Myomo price to book ratio MYO

Market value divided by the book value of the company's net assets, since 2017.

Today, Oct 23, 2026: 8.2×
9-year median: 2.8×
Against its 9-year history: 80th; percentile: 0 is its lowest day, 100 its highest
9-year range: 0.4× to 21.4×
Peer median: 2.6×

Myomo's price to book ratio is 8.2× as of Oct 23, 2026.

That is above its 9-year median of 2.8×, higher than on 80% of days in the last 9 years.

Over that time it ranged from 0.4× in Dec 2022 to 21.4× in Jan 2025.

The median for 7 medical instruments and supplies stocks of a similar size is 2.6×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	8.2×	1.9×	11.8×
2025	2.7×	1.8×	21.4×
2024	20.7×	6.9×	20.7×
2023	12.1×	0.4×	12.5×
2022	0.5×	0.4×	4.4×
2021	3.6×	2.6×	6.8×
2020	2.4×	0.5×	7.1×
2019	1.2×	1.2×	3.4×
2018	2.0×	1.8×	12.5×
2017	8.9×	4.8×	15.8×

Against its peers

Companies in Medical - Instruments & Supplies nearest Myomo's size, closest first, today.

Company	Price to book ratio
MYOMyomo	8.2×
APTAlpha Pro Tech	0.9×
NEPHNephros	3.2×
KEQUKewaunee Scientific	1.3×
PDEXPro DEX	4.2×
UTMDUtah Medical Products	1.9×
INFUInfuSystem	4.7×
EMBCEmbecta	n/m
Peer median	2.6×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Myomo

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.